Back to Search
WILLIAM PITTS, MD
MD
Anatomic Pathology Physician
NPI: 1639110471Individual
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
G51515(CA)
Research & Publications (20)
Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromatase.
PMID 17506871·BJU Int·2007
6-review
Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
PMID 15125967·Bioorg Med Chem Lett·2004
8-other
The clinical rationale for immediate androgen deprivation without estrogen deprivation.
PMID 15040875·Clin Prostate Cancer·2003
8-other
Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.
PMID 12127522·Bioorg Med Chem Lett·2002
7-preclinical
Isoxazolines as potent antagonists of the integrin alpha(v)beta(3).
PMID 10633036·J Med Chem·2000
8-other
Implementation of an insulin therapy protocol: applying the Baldrige approach.
PMID 19451615·Am J Health Syst Pharm·2009
8-other
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
PMID 19376699·Bioorg Med Chem Lett·2009
7-preclinical
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
PMID 19652024·J Pharmacol Exp Ther·2009
7-preclinical
Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation.
PMID 19272774·Bioorg Med Chem Lett·2009
7-preclinical
Re: Additional treatment for pT3 prostate cancer: now, later or never.
PMID 18564235·BJU Int·2008
8-other
Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder cancer using a panel of biomarkers: a high-throughput tissue microarray analysis.
PMID 18489407·BJU Int·2008
8-other
Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.
PMID 16860461·Eur Urol·2007
8-other
Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
PMID 17027261·Bioorg Med Chem Lett·2007
8-other
Re: The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
PMID 16753453·J Urol·2006
8-other
RE: Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.
PMID 15758829·J Urol·2005
8-other
Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
PMID 15780616·Bioorg Med Chem Lett·2005
8-other
Re: osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy.
PMID 15821604·J Urol·2005
8-other
Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.
PMID 16286153·Urology·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 305 PARK CREEK DR
CLOVIS, CA 93611 - Phone
- (559) 326-2815
Quick Facts
- NPI
- 1639110471
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile